You are here: Industry Insights > Merck & Co.

News List

EMA panel backs approval of AstraZeneca, Merck & Co.'s PARP inhibitor Lynparza in breast cancer firstwordpharma
March 03, 2019
AstraZeneca and partner Merck & Co. on Friday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval of the PARP inhibitor Lynparza (olaparib) as monotherapy for the treatment of HER2-nega
Merck's Keytruda looks to zoom past Opdivo with fast head and neck cancer review fiercepharma
February 12, 2019
Merck & Co.’s Keytruda is duking it out with Bristol-Myers Squibb’s Opdivo in the head and neck cancer marketplace, but Keytruda just took one step toward a green light that would give it a big edge.
Sanofi, Merck win FDA nod for 6-in-1 pediatric vaccine Vaxelis fiercepharma
January 03, 2019
Pharma giants Sanofi and Merck & Co. each have big ambitions in vaccines, and ahead of the new year, the companies secured FDA approval for a six-in-one shot to be marketed as Vaxelis.
These 20 women are 2018's Fiercest in the life sciences industry. fiercepharma
December 12, 2018
Merck & Co.’s experimental Ebola vaccine rVSV-ZEBOV has been deployed widely in the Democratic Republic of Congo. But experts are calling on the U.S. government to send CDC specialists
Merck promotes oncology, vaccine executives to replace Adam Schechter in commercial rejig fiercepharma
December 12, 2018
Merck & Co. boasted some major success in the sales department this year, but the company’s commercial organization will still get a makeover for 2019.
Merck & Co. says global human health president Adam Schechter to step down; "reshapes" its commercial organisation firstwordpharma
December 11, 2018
Merck & Co. on Monday announced that Adam Schechter, president of the drugmaker's global human health division, will be stepping down at the end of the year. The company noted that Schechter will be transitioning to an advisory role to CEO Ken Frazier.
Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case fiercepharma
December 05, 2018
Shortly after the U.S. Supreme Court agreed in June to hear Merck & Co.’s appeal in the years-long Fosamax liability litigation, acting Solicitor General Jefferey Wall asked for permission to present oral arguments.
Merck's rolling with RotaTeq in China while phasing out a discounted Africa supply deal pharmatimes
November 14, 2018
When supplies are strained, what gives? For Merck & Co., in the midst of global production constraints, it's phasing out shipments of cut-rate RotaTeq doses to Africa
Racing with Merck, Pfizer wins FDA 'breakthrough' tag for 20-valent pneumococcal vaccine fiercepharma
November 09, 2018
Pfizer and Merck are racing to the market with their next-gen pneumococcal candidates, and on Thursday, Pfizer's program got a major boost. The FDA granted the ...
'Unprecedented' demand for Merck's Gardasil drives monster Q3 fiercepharma
November 09, 2018
Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing. The company sees more growth

Previous page 1 2 Next page